This inventor holds 1 USPTO granted patent. Top assignees: Boston University, Harvard College, The Broad Institute, Inc.. Active years: 2025.
Company Filing History:
1 out of 832 
1 out of 3,069 
1 out of 480 
Years Active: 2025
Title: Jenn Abelin: Innovator in Immunogenic Compositions
Introduction
Jenn Abelin is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of immunology, particularly in the development of immunogenic compositions aimed at combating diseases.
Latest Patents
Abelin holds a patent for "Immunogenic compositions and use thereof." This patent describes immunogenic compositions that comprise one or more polypeptides capable of binding to Major Histocompatibility Complex (MHC) class I. The polypeptides are derived from proteins of SARS-CoV-2. The patent also outlines methods for treating and preventing diseases using these immunogenic compositions. She has 1 patent to her name.
Career Highlights
Throughout her career, Jenn Abelin has worked with esteemed institutions such as The Broad Institute, Inc. and Harvard College. Her work has been instrumental in advancing research in immunology and vaccine development.
Collaborations
Abelin has collaborated with notable colleagues, including Pardis Sabeti and Shira Weingarten-Gabbay. These collaborations have further enriched her research and contributions to the scientific community.
Conclusion
Jenn Abelin is a trailblazer in the field of immunogenic research, with her innovative work paving the way for advancements in disease prevention and treatment. Her contributions are vital in the ongoing fight against infectious diseases.